|
||||
|
Product trade name: Cerepar
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: Cerepar available forms, composition, doses: Cerepar destination | category: Indications and usages, anatomical therapeutic chemical and diseases classification codes: Pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers: Online pharmacy, drugstores, pharma, health and beauty shops selling this or related pharmaceutical products: There is an additional general information about this medication active ingredient cinnarizine: Pharmacological action Cerepar is a calcium channel blocker class IV with a predominant effect on the brain vessels, a derivative of piperazine. This medication improves cerebral, coronary and peripheral circulation. Cerepar violates the entrance of calcium ions into vascular smooth muscle cells. This drug lowers the tone of arteriolar smooth muscle, decreases the vasoconstrictor response to biogenic substances (epinephrine, norepinephrine, bradykinin). Cinnarizine reduces the excitability of the vestibular apparatus. In patients with impaired peripheral circulation Cerepar improves blood flow and potentiates postischemic hyperemia. This medicine increases the resistance of tissue to hypoxia. Pharmacokinetics After oral administration Cerepar is absorbed from the gastrointestinal tract, Cmax in plasma is reached after 1-4 h. The plasma protein binding is 91%. This medication is metabolized. T1/2 is 3-6 hours. Cerepar is eliminated through the intestine largely unchanged, with the urine - mainly in the form of metabolites. Why is Cerepar prescribed? Ischemic attacks (including the residual effects after a stroke). Labyrinth disorders (including for maintenance therapy for dizziness, tinnitus, nystagmus, nausea and vomiting of labyrinth origin). Motion sickness (as a prophylactic agent). Prophylaxis of migraine. Meniere's disease. Prevention and treatment of disorders of peripheral circulation - atherosclerosis, thromboangiitis obliterans, Raynaud's disease, diabetic angiopathy, acrocyanosis. Dosage and administration The dosage regimen is individual. Cerepar is taken orally in 25-50-75 mg 3 times / day after a meal. If necessary, the treatment can begin with half the dose and gradually increasing. To achieve the optimal therapeutic effect is used continuously for several months. Cerepar side effects, adverse reactions Digestive system: dyspepsia, dry mouth, rarely - cholestatic jaundice. CNS: headache, drowsiness; in elderly patients in long-term use may be extrapyramidal symptoms, depression. Allergic reactions: rarely - skin rash. Other: weight gain, increased sweating, in rare cases - lupus-like syndrome, lichen planus. Cerepar contraindications Hypersensitivity to cinnarizine. Using during pregnancy and breastfeeding During pregnancy and lactation (breastfeeding) Cerepar usage is possible only in exceptional cases, when the expected benefit to the mother far outweighs the potential risk to the fetus or infant. Special instructions Use Cerepar with caution in patients with hypertension. With prolonged use is recommended to perform control examination of liver, kidney, peripheral blood picture. At the beginning of treatment you should refrain from potentially hazardous activities that require attention and speed of psychomotor reactions. Cerepar drug interactions When this drug applied simultaneously with: - tricyclic antidepressants, hypnotics, drugs that have a sedative effect, alcohol, ethanol-containing medication increases the effects on the CNS. - antihypertensive drugs increased hypotensive effect. - nootropics, vasodilators - increases the action of nootropic drugs and vasodilators. - phenylpropanolamine reduces sedation effect of Cerepar. Cerepar in case of emergency / overdose Treatment: gastric lavage, taking activated charcoal, symptomatic therapy. There is no a specific antidote.
Comments
|
|
|||
|
||||